Cleared Traditional

K910535 - SYNCHRON C-REACTIVE PROTEIN REAGENT

K910535 is an FDA 510(k) clearance for SYNCHRON C-REACTIVE PROTEIN REAGENT, manufactured by Beckman Instruments, Inc.. The device is a Class 2 Immunology device with product code DCN cleared through the Traditional 510(k) pathway after a 63-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
63d
Days
Class 2
Risk

K910535 is an FDA 510(k) clearance for the SYNCHRON C-REACTIVE PROTEIN REAGENT. Classified as System, Test, C-reactive Protein (product code DCN), Class II - Special Controls.

Submitted by Beckman Instruments, Inc. (Brea, US). The FDA issued a Cleared decision on April 12, 1991 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5270 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K910535

510(k) Number K910535 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 1991
Decision Date April 12, 1991
Days to Decision 63 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 105d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DCN Device Classification - Class 2, Special Controls

Product Code DCN System, Test, C-reactive Protein
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5270
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DCN System, Test, C-reactive Protein

All 69
Devices cleared under the same product code (DCN) and FDA review panel - the closest regulatory comparables to K910535.
CHROMALEX C-REACTIVE PROTEIN LATEX TEST SYSTEM
K955042 · Shared Systems, Inc. · Dec 1995
SPQ CRP CONTROL LEVEL II
K935075 · Incstar Corp. · Jan 1994
EYE SPOT CRP TEST
K932180 · J.S. Medical Assoc. · Aug 1993
RHEUMAJET CRP
K910686 · Biokit USA, Inc. · Mar 1991
CROMATEST RHEUMATOID DIAGNOSTIC/CRP LATEX TEST
K904497 · Biotrax, Inc. · Nov 1990
RAPITEX (R) CRP NEW
K903853 · Behring Diagnostics, Inc. · Aug 1990